Artificial intelligence has the potential to improve the analysis of medical image data. For example, algorithms based on deep learning can determine the location and size of tumors. This is the ...

Patients on the Tevimbra combo had a 20 percent reduction in risk of death compared to those on chemotherapy alone.

Artificial intelligence has the potential to improve the analysis of medical image data. For example, algorithms based on deep learning can determine the location and size of tumors.

Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

AIC-100 is under clinical development by AffyImmune Therapeutics and currently in Phase I for Anaplastic Thyroid Cancer.

Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.

The platinum chemotherapy shortage, first announced on Feb. 10, 2023, resulted in a modest absolute reduction in plati ...

At the American Society of Hematology annual meeting, a roundtable discussion highlighted the evolving role of minimal residual disease (MRD) as a treatment endpoint in multiple myeloma, exploring its ...

The FDA has approved tislelizumab plus chemotherapy for the treatment of patients with newly diagnosed, locally advanced or ...

Through interviews and articles infused with expert insight, progress against this cancer that develops in the bone marrow ...

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no ...